BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, a bioelectronic medicine company developing wearable therapies for chronic disease, announces two validating pieces of news for the non-invasive ...
Cala Health is getting noticed, and it's not hard to figure out why. The Burlingame, CA-based company is targeting a large and under-penetrated market opportunity with its watch-like device for ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...
"Cala Health has emerged a pioneer in treating ET for the upper limbs through peripheral nerve stimulation. The Cala Trio™ delivers precise electrical pulses to the median and radial nerves in the ...
- Data presented at the Virtual ISPOR Europe 2020 conference underscore the growing need for ET treatment and support Cala Trio as a safe and effective ET therapy in real-world settings - Essential ...
In August, Cala Health Inc. reported results from its pivotal PROSPECT study showing significant improvement in hand tremors with use of its Cala Trio wearable neuromodulation therapy. Now the company ...
The Cala Trio is a wrist-worn biolectronic device that treats essential tremor. Years ago, Kate Rosenbluth, PhD, watched as a neurosurgeon delivered the news to one of his patients that a pre-existing ...
Cala Trio allows patients to gain relief from hand tremors in the comfort of their homes SANTA CLARA, California, Jan. 9, 2020 /PRNewswire/ -- Based on its recent analysis of the North American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results